BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2018

View Archived Issues

Rhythm acquires rights to Takeda GOAT inhibitor for Prader-Willi syndrome

Read More

Relationship between PACE4 expression and prognosis differs in colorectal cancer

Read More

PRAME found highly expressed in salivary gland cancer

Read More

FDA grants BLA priority review for moxetumomab pasudotox in hairy cell leukemia

Read More

FDA grants fast track designation for TAR-200 in muscle invasive bladder cancer

Read More

Retrophin initiates pivotal phase III DUPLEX study of sparsentan

Read More

Novartis patents new TLR7/8/9 antagonists

Read More

MedImmune divulges novel anti-VEGF-A antibodies for cancer

Read More

Novel secretomes disclosed by researchers from Korea

Read More

Eli Lilly discovers HAVcr-2-targeting antibodies

Read More

Phase I trial of KA-34 is currently recruiting participants

Read More

FDA grants orphan drug designation for BPN-14770 as treatment of fragile X syndrome

Read More

PRDM15-targeting ASOs presented by A*STAR

Read More

Topline results from phase II study of fostamatinib in IgA nephropathy

Read More

European Commission grants orphan drug designation to Altemia for sickle cell disease

Read More

Patient recruitment ongoing in phase I/II trial of ST-400

Read More

EMA validates MAA for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer

Read More

GenSight reports topline results from REVERSE trial of GS-010 in LHON

Read More

Personal Genome Diagnostics, Five Prime Therapeutics to develop bemarituzumab companion diagnostic

Read More

SpinalCyte reports data from phase I/II trial of CybroCell

Read More

ThromboGenics reports phase I/II topline data on THR-317 for DME

Read More

Eisai submits sNDA for pediatric use of Fycompa

Read More

Pfizer and Allogene enter asset contribution agreement for Pfizer's CAR T portfolio

Read More

SOX-9 unveiled as potential prognostic marker in lymphoma

Read More

Sellas reports interim phase IIb data on Herceptin + NeuVax in breast cancer

Read More

Nkx-6.1 identified as diagnostic marker of lung and pancreatic NETs

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing